In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...
A recent study published on the medRxiv* preprint server discusses the role of lateral flow device (LFD) testing in potentially improving coronavirus disease 2019 (COVID-19) isolation policies. Study: ...
Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial. An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce ...
Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.
In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...
Nanoparticles are emerging as powerful tools for research, therapeutic, and diagnostic applications. In particular, their utility as lateral flow test probes has gained prominence amid the COVID-19 ...
We preselected all newsletters you had before unsubscribing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results